Insecticides (India) · NSE: INSECTICID · BSE: 532851

Q2 FY23 results · Jul–Sep 2022

Insecticides (India) reported revenue from operations of ₹582.21 crore (up 31.1% from Q2 FY22) and net profit of ₹44.83 crore (up 7.1% from Q2 FY22) for Q2 FY23 (Jul–Sep 2022), on a consolidated basis.

Consolidated · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations582.21443.94+31.1%560.69+3.8%
Other income0.28(0.31)Turned profit0.19+46.6%
Total income582.49443.63+31.3%560.88+3.9%
Profit before share of associates & JVs and tax59.6055.72+7.0%50.62+17.7%
Share of profit/(loss) of associates & JVs0.170.120.31
Net profit for the period44.8341.88+7.1%38.31+17.0%
EPS, basic (₹)15.1521.22−28.6%19.41−21.9%
Net margin (%)7.79.46.8

This company reports a share of profit/(loss) from associates and joint ventures. BSE’s filing format records that share after tax, so it is shown on its own line. The company’s own statement may add it before its “profit before tax” line.

Standalone · ₹ crore
ItemQ2 FY23Q2 FY22YoYQ1 FY23QoQ
Revenue from operations582.21443.94+31.1%560.69+3.8%
Other income0.28(0.31)Turned profit0.19+46.6%
Total income582.49443.63+31.3%560.88+3.9%
Profit before tax59.6055.72+7.0%50.62+17.8%
Net profit for the period44.6741.76+7.0%38.00+17.6%
EPS, basic (₹)15.0921.16−28.7%19.26−21.7%
Net margin (%)7.79.46.8
Consolidated
Filed with BSE
18 Nov 2022, 17:04 IST
Board meeting
07 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
18 Nov 2022, 17:04 IST
Board meeting
07 Nov 2022
Period
01 Jul 2022 to 30 Sep 2022
Review status
Unaudited
Source
XBRL filing on BSE